AVTX · Avalo Therapeutics, Inc.
Market Cap
$1.05B
Shares
53.63M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Garry Neil | Chief Executive Officer, President, Chairman of the Board and principal executive officer | $1,075,362 |
| Christopher Sullivan | Chief Financial Officer and principal financial officer | $607,645 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Garry Neil | Chief Executive Officer, President, Chairman of the Board and principal executive officer | $1,332,828 |
| Stephen Smolinski | Former Chief Commercial Officer | $990,879 |
| Michael Cola | Former Chief Executive Officer and former principal executive officer | $945,417 |
| Christopher Sullivan | Chief Financial Officer and principal financial officer | $768,549 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michael Cola | Former Chief Executive Officer and former principal executive officer | $2,693,811 |
| Schond Greenway | Former Chief Financial Officer and former principal financial officer | $1,676,585 |
| H. Jeffrey Wilkins | Former Chief Medical Officer | $1,249,985 |
| Garry Neil | Chief Executive Officer, President, Chairman of the Board and principal executive officer | $1,234,071 |
| Christopher Sullivan | Chief Financial Officer and principal financial officer | $627,642 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Cola | Former Chief Executive Officer and former principal executive officer | $3,820,306 |
| Garry Neil | Chief Scientific Officer | $2,688,804 |
| H. Jeffrey Wilkins | Former Chief Medical Officer | $1,487,778 |
| Joseph Miller | Former Chief Financial Officer, former principal financial officer, and former principal executive officer | $232,269 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Simon Pedder | Former Executive Chairman of the Board | $3,776,649 |
| Pericles Calias | Former Chief Scientific Officer | $1,345,362 |
| Joseph Miller | Former Chief Financial Officer, former principal financial officer, and former principal executive officer | $1,170,598 |
| Peter Greenleaf | Former Chief Executive Officer and former Principal Executive Officer | $735,204 |
| Garry Neil | Chief Scientific Officer | — |
| H. Jeffrey Wilkins | Chief Medical Officer | — |
| Michael Cola | Chief Executive Officer and principal executive officer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Peter Greenleaf | Former Chief Executive Officer and former Principal Executive Officer | $5,090,787 |
| Joseph Miller | Former Chief Financial Officer, former Principal Financial Officer, and former Principal Executive Officer | $672,985 |
| Pericles Calias | Former Chief Scientific Officer | $351,305 |
| Simon Pedder | Former Executive Chairman of the Board | $27,644 |
Executive changes
Key facts
CIK
1534120
CUSIP
05338F306
13F (30d)
129 filings
120 filers
Visit website
Investor relations